Dr. Lal PathLabs Q4 Results
- BSE: 539524
- NSE: LALPATHLAB
- ISIN: INE600L01024
- Sector: Healthcare Facilities
BSE
1,698.50
52.10 (3.16%)
52.10 (3.16%)Volume53.98 K
Updated: Tue 19 May, 2026 | 15:29:46
NSE
1,703.7057.40 (3.49%)
57.40 (3.49%)Volume5.40 L
Updated: Tue 19 May, 2026 | 15:50:32
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹702.70 Cr.(16.61%)
- Operating Profit₹142.20 Cr.(7.18%)
- Profit After Tax₹131.30 Cr.(-15.20%)
- Operating Margin20.24%(-8.09%)
Note: Comparison is on YoY basis
Quarterly - Dr. Lal PathLabs Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 560.50 | 552.70 | 1.41% | 437.40 | 19.28% |
| Depreciation/ Amortization | 44.60 | 42.10 | 5.94% | 36.60 | 22.45% |
| Operating Income | 142.20 | 107.10 | 32.77% | 108.05 | 7.18% |
| Net Income | 131.30 | 90.50 | 45.08% | 84.54 | -15.20% |
| Other Operating Expenses Total | 151.30 | 121.50 | 24.53% | 110.80 | 23.19% |
| Net Income Before Taxes | 160.10 | 124.30 | 28.80% | 119.85 | 4.30% |
| Total Revenue | 702.70 | 659.80 | 6.50% | 545.44 | 16.61% |
| Selling/ General/ Admin Expenses Total | 229.40 | 230.30 | -0.39% | 181.08 | 18.91% |
| Diluted Normalized EPS | 7.85 | 6.74 | 16.48% | 5.08 | -15.45% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.